Company / Gross Profit per Share
Myriad Genetics, Inc. Gross Profit per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$7.10
FY2025
5-year range
$6.48 / $7.32
FY2022-FY2025
Trend
-3.0%
vs FY2024
Sector context
#12 of 29
Health Care
What the data says
At $7.10, Myriad Genetics, Inc.'s gross profit per share ranks #12 of 29 in the Health Care sector. Improved from $6.86 to $7.10 over the past 2 years.
Based on SEC 10-K filings.
7.10 in FY2025 with a 3-year CAGR of +3.1%.
Improved from $6.86 to $7.10 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#12 of 29 in Health CareTop 41% of 29This company $7.10 Sector average $8.11
▼
-12.4% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share decreased 3.0% year-over-year.
- Ranks #12 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.10 | -3.0% |
| FY2024 | $7.32 | +6.7% |
| FY2023 | $6.86 | +5.8% |
| FY2022 | $6.48 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026